Boston Scientific announces results for first quarter 2025
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Boston Scientific (BSX) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY25 EPS Guidance
April 23, 2025 6:31 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.75, $0.08 better than the analyst estimate of $0.67. Revenue for the quarter came in at $4.66 billion versus the consensus estimate of $4.57 billion.
GUIDANCE:
Boston Scientific sees FY2025 EPS of $2.87-$2.94, versus the consensus of... More
